121 related articles for article (PubMed ID: 36511003)
1. A prospective randomized comparison of simultaneous integrated boost with sequential boost intensity-modulated radiotherapy in locally advanced head and neck cancer.
Mani N; Aggarwal SK; Kumar I; Mandal A; Jaiswal G; Ranjan R; Jaiswal AK; Gupta N; Singh A; Mourya A; Aggarwal LM; Choudhary S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S455-S459. PubMed ID: 36511003
[TBL] [Abstract][Full Text] [Related]
2. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
Mandal A; Choudhary S; Mani N; Aggarwal SK
J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy.
Rotondi M; Facondo G; Mossa S; Vullo G; Angelicone I; Valeriani M; Osti MF
Int J Colorectal Dis; 2023 May; 38(1):125. PubMed ID: 37171509
[TBL] [Abstract][Full Text] [Related]
6. An experience with simultaneous integrated boost-volumetric-modulated arc therapy in the definitive treatment of head and neck cancer: An Indian data.
Shivananjappa R; Mandal SK; Vishwanathan B; Geeta SN
J Cancer Res Ther; 2023; 19(2):283-288. PubMed ID: 37006066
[TBL] [Abstract][Full Text] [Related]
7. A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer.
Grover A; Soni TP; Patni N; Singh DK; Jakhotia N; Gupta AK; Sharma LM; Sharma S; Gothwal RS
Radiat Oncol J; 2021 Mar; 39(1):15-23. PubMed ID: 33794570
[TBL] [Abstract][Full Text] [Related]
8. Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
Franco P; De Bari B; Arcadipane F; Lepinoy A; Ceccarelli M; Furfaro G; Mistrangelo M; Cassoni P; Valgiusti M; Passardi A; Casadei Gardini A; Trino E; Martini S; Iorio GC; Evangelista A; Ricardi U; Créhange G
Radiat Oncol; 2018 Sep; 13(1):172. PubMed ID: 30201015
[TBL] [Abstract][Full Text] [Related]
9. Concurrent weekly cisplatin and simultaneous integrated boost intensity-modulated radiotherapy of locally advanced squamous cell carcinoma of the head and neck.
Dubinský P; Jeremic B; Švajdová M; Barilíková G; Matula P; Nadzonová D; Vojtek V
Klin Onkol; 2022; 35(4):307-314. PubMed ID: 35989088
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.
Forster T; Hommertgen A; Häfner MF; Arians N; König L; Harrabi SB; Schlampp I; Köhler C; Meixner E; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Golatta M; Hof H; Krug D; Debus J; Hörner-Rieber J
Radiother Oncol; 2021 Oct; 163():165-176. PubMed ID: 34480960
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
Spiotto MT; Weichselbaum RR
PLoS One; 2014; 9(4):e94456. PubMed ID: 24714187
[TBL] [Abstract][Full Text] [Related]
13. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
[TBL] [Abstract][Full Text] [Related]
14. Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
Hörner-Rieber J; Forster T; Hommertgen A; Haefner MF; Arians N; König L; Harrabi SB; Schlampp I; Weykamp F; Lischalk JW; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Hof H; Krug D; Debus J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1311-1324. PubMed ID: 33321192
[TBL] [Abstract][Full Text] [Related]
15. IMRT-SIB with concurrent and neo-adjuvant platinum-based chemotherapy for locally advanced head and neck squamous cell cancer: analysis of clinical outcomes in a retrospective series of a single institution.
Mazzeo E; Antognoni P; Parmiggiani M; D'Ambrosio C; De Marco G; Marra L; Gottardi G; Bertoni F
Tumori; 2014; 100(6):652-9. PubMed ID: 25688499
[TBL] [Abstract][Full Text] [Related]
16. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
[TBL] [Abstract][Full Text] [Related]
18. Comparative treatment planning study on sequential vs. simultaneous integrated boost in head and neck cancer patients: Differences in dose distributions and potential implications for clinical practice.
Stromberger C; Ghadjar P; Marnitz S; Thieme AH; Jahn U; Raguse JD; Karaj-Rossbacher E; Böttcher A; Jamil B; Budach V
Strahlenther Onkol; 2016 Jan; 192(1):17-24. PubMed ID: 26462675
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis.
Jiang L; Zhang Y; Yang Z; Liang F; Wu J; Wang R
Medicine (Baltimore); 2019 Aug; 98(34):e16942. PubMed ID: 31441887
[TBL] [Abstract][Full Text] [Related]
20. Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma.
DE Felice F; Musio D; Serpone M; Vavalle G; Marchetti C; Tombolini V
Anticancer Res; 2022 Dec; 42(12):5909-5915. PubMed ID: 36456162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
